ANIDO ARMANDO - Insider Non-Derivative Transactions at Zynerba Pharmaceuticals, Inc. (ZYNE) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Oct 10, 2023, ANIDO ARMANDO's relationship to Zynerba Pharmaceuticals, Inc. (ZYNE) is Director,Officer (Chairman & Chief Exec. Officer), and currently has 610,000 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ZYNE insiders.

Data Source: SEC.
ANIDO ARMANDO - Insider Non-Derivative Transactions of ZYNE Common Stock
ANIDO ARMANDO - Insider Non-Derivative Transactions at ZYNE
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Oct 11, 2023 U -- (Common Stock) 13297 0 0
Oct 11, 2023 U -- (Common Stock) 26595 0 0
Oct 11, 2023 U -- (Common Stock) 610000 0 0
Oct 11, 2023 U -- (Common Stock) 566722 0 370000
Oct 11, 2023 Acquisition -- (Common Stock) 240000 0 610000
Sep 14, 2023 Sell -- (Common Stock) 17830 1.33 936722
Sep 13, 2023 Acquisition -- (Common Stock) 64747 0 954552
Feb 9, 2023 F -- (Common Stock) 12547 0.6 889805
Feb 8, 2023 Acquisition -- (Common Stock) 45406 0 902352
Feb 2, 2023 F -- (Common Stock) 11726 0.6 856946
Feb 1, 2023 Acquisition -- (Common Stock) 42437 0 868672
Jan 25, 2023 Acquisition -- (Common Stock) 250000 0 826235
Jan 24, 2023 Sell -- (Common Stock) 35453 0.6 576235